Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • manasarai2009
    Junior Member
    • Apr 2014
    • 3

    #1

    RNA seq TCGA

    Hi

    I have downloaded the RNA seq data RPKM values from TCGA. For each gene
    RAW COUNTS, MEDIAN LENGTH NORMALIZED, RPKM VALUES were given. I understood the raw counts and rpkm values, but i do not clearly understand what are these median length normalized values. could anyone please let me know....

    Example:

    GENE raw_counts median_length_normalized RPKM
    ACOT7|11332_calculated 1835 55.9325 7.4205
    ADAR|103_calculated 29550 328.378 43.5654
    Manasa
  • Richard Finney
    Senior Member
    • Feb 2009
    • 701

    #2
    The Cancer Genome Atlas (TCGA) is a landmark cancer genomics program that sequenced and molecularly characterized over 11,000 cases of primary cancer samples. Learn more about how the program transformed the cancer research community and beyond.

    Step 5: Calculate quantification at the gene level.

    Quantification at the gene level is determined by collapsing the transcript
    level quantifications onto their associated gene loci. Raw read counts,
    coverage, and RPKM are reported for each gene. Raw read counts for a given
    GeneX is the sum of reads aligned to all transcripts associated with that
    gene. Coverage for a given GeneX is determined by: sum of bases aligned to
    all transcripts associated with GeneX / length of GeneX. RPKM for a given
    GeneX is calculated by: (raw read counts × 10^9) / (total reads × length of
    GeneX). “Total reads” is the lane yield after removing poor quality reads.
    In both the coverage and RPKM calculations, the length of GeneX is defined as
    the median length of all transcripts associated with GeneX.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...